Auspex Pharmaceuticals Announces Series B Financing; Appointment of Ajit Gill as President and Chief Executive Officer
David Tierney, M.D. Joins Thomas, McNerney & Partners as Entrepreneur-in-Residence
Ocera Therapeutics Closes $35.5 Million Series C Financing
© 2003 Thomas McNerney & Partners - All Rights Reserved.
